Ligand validation:4ZUK

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 4ZUK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ZUK_NAD_C_602	43%	28%	0.114	0.907	1.53	1.37	5	4	0	0	61%	0.6136
4ZUK_NAD_H_602	43%	17%	0.108	0.915	1.7	1.94	4	8	0	0	52%	0.4495
4ZUK_NAD_F_602	42%	17%	0.109	0.913	1.62	2	5	7	0	0	52%	0.5227
4ZUK_NAD_B_602	41%	16%	0.104	0.905	1.61	2.03	5	9	0	0	52%	0.5227
4ZUK_NAD_D_602	40%	23%	0.133	0.913	1.56	1.62	6	5	0	0	61%	0.6136
4ZUK_NAD_G_602	39%	14%	0.119	0.912	1.66	2.18	5	9	0	0	52%	0.5227
4ZUK_NAD_A_602	32%	26%	0.139	0.882	1.56	1.43	7	5	0	0	61%	0.6136
4ZUK_NAD_E_602	27%	27%	0.153	0.871	1.56	1.41	5	4	0	0	61%	0.6136
6O4C_NAD_G_601	94%	3%	0.069	0.97	4.99	1.35	16	4	1	0	100%	1
6O4B_NAD_H_601	93%	3%	0.074	0.968	5.16	1.22	15	4	1	0	100%	1
6O4E_NAD_D_601	87%	2%	0.092	0.964	5.15	1.41	16	6	1	0	100%	0.93
6O4L_NAD_A_604	87%	3%	0.095	0.966	5	1.25	15	5	1	0	100%	0.93
4X0T_NAD_B_601	84%	21%	0.108	0.97	2	1.35	14	6	0	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.